Article
To Monetize Or Not To Monetize? The Question Late-Stage Life Sciences Companies Should Be Asking
Over the last few years, royalty monetization deals have solidified their status as important financing alternatives for late-stage life sciences companies to consider in their fundraising initiatives.
Goodwin Procter LLP